TGF-β in the cardiovascular system:: Molecular mechanisms of a context-specific growth factor

被引:39
作者
Topper, JN [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc, Stanford, CA 94305 USA
关键词
D O I
10.1016/S1050-1738(00)00061-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transforming growth factor bera-l is the prototypical member of a class of growth factors whose actions have been strongly implicated in a number of pathophysiologic processes including chronic vascular diseases such as atherosclerosis and hypertension. One of the hallmarks of this class of growth factors is the diverse nature of their actions; a characteristic that is thought to arise from the fact that the effects of these factors are very dependent upon the particular cellular context in which they operate. There has been substantial progress in understanding the molecular signaling mechanisms utilized by these factors. These findings ave beginning to provide a mechanistic framework with which to understand the complex and pleiotropic actions of these factors on cells and tissues of the cardiovascular system. (C) 2001, Elsevier Science Inc.
引用
收藏
页码:132 / 137
页数:6
相关论文
共 42 条
[1]  
BAKER JC, 1997, CURR OPIN GENE DEV, V74, P67
[2]   Serum levels of the TGF-beta receptor are increased in atherosclerosis [J].
Blann, AD ;
Wang, JM ;
Wilson, PB ;
Kumar, S .
ATHEROSCLEROSIS, 1996, 120 (1-2) :221-226
[3]   MEKK-1, a component of the stress (stress-activated protein kinase c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells [J].
Brown, JD ;
DiChiara, MR ;
Anderson, KR ;
Gimbrone, MA ;
Topper, JN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) :8797-8805
[4]  
Frey RS, 1997, CANCER RES, V57, P628
[5]   CREB-binding protein p300 are transcriptional coactivators of p65 [J].
Gerritsen, ME ;
Williams, AJ ;
Neish, AS ;
Moore, S ;
Shi, Y ;
Collins, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :2927-2932
[6]   Biomechanical activation: An emerging paradigm in endothelial adhesion biology [J].
Gimbrone, MA ;
Nagel, T ;
Topper, JN .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (08) :1809-1813
[7]   THE SERUM CONCENTRATION OF ACTIVE TRANSFORMING GROWTH-FACTOR-BETA IS SEVERELY DEPRESSED IN ADVANCED ATHEROSCLEROSIS [J].
GRAINGER, DJ ;
KEMP, BR ;
METCALFE, JC ;
LIU, AC ;
LAWN, RM ;
WILLIAMS, NR ;
GRACE, AA ;
SCHOFIELD, PM ;
CHAUHAN, A .
NATURE MEDICINE, 1995, 1 (01) :74-79
[8]   ACTIVATION OF TRANSFORMING GROWTH-FACTOR-BETA IS INHIBITED IN TRANSGENIC APOLIPOPROTEIN(A) MICE [J].
GRAINGER, DJ ;
KEMP, PR ;
LIU, AC ;
LAWN, RM ;
METCALFE, JC .
NATURE, 1994, 370 (6489) :460-462
[9]   PIVOTAL ROLE FOR TGF-BETA IN ATHEROGENESIS [J].
GRAINGER, DJ ;
METCALFE, JC .
BIOLOGICAL REVIEWS, 1995, 70 (04) :571-596
[10]   Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): New insights in pathogenesis, complications, and treatment [J].
Haitjema, T ;
Westermann, CJJ ;
Overtoom, TTC ;
Timmer, R ;
Disch, F ;
Mauser, H ;
Lammers, JWJ .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (07) :714-719